Impact of reduction in early- and late-systolic functional mitral regurgitation on reverse remodelling after cardiac resynchronization therapy
- PMID: 20501482
- DOI: 10.1093/eurheartj/ehq134
Impact of reduction in early- and late-systolic functional mitral regurgitation on reverse remodelling after cardiac resynchronization therapy
Abstract
Aims: To examine whether the presence of pre-pacing functional mitral regurgitation (MR) and its improvement would affect the extent of left ventricular (LV) reverse remodelling after cardiac resynchronization therapy (CRT).
Methods and results: Echocardiographic assessment was performed in 83 patients before and 3 months after CRT. Total MR volume and the early- and late-systolic MR flow rate were assessed. At 3 months, there was reduction in total MR volume (38 ± 20 vs. 33 ± 21 mL) with decrease in both early- (71 ± 52 vs. 60 ± 51 mL/s) and late-systolic (49 ± 46 vs. 42 ± 46 mL/s) MR flow rate (all P < 0.05). Receiver-operating characteristic curve found that an 11% decrease in total MR volume was associated with LV reverse remodelling [defined by the reduction in LV end-systolic volume (LVESV) of ≥15%] [sensitivity, 90%; specificity, 80%; area under the curve (AUC), 0.85; P < 0.001]. The improvement in early- and late-systolic MR was also associated with LV reverse remodelling, in which improvement in early-systolic MR had higher sensitivity, specificity, and AUC than late-systolic MR. The extent of reverse remodelling with gain in LV ejection fraction and forward stroke volume was greatest in patients with improvement in total MR, intermediate in those with mild or no MR at baseline, and the least in those without improvement in total MR (LVESV, -29.8 ± 12.0 vs. -18.6 ± 16.6 vs. -5.5 ± 8.6%; ejection fraction, 11.8 ± 6.2 vs. 7.0 ± 6.8 vs. 3.0 ± 5.0%; forward stroke volume, 43.1 ± 37.9 vs. 21.1 ± 26.1 vs. 6.8 ± 34.6%; all P < 0.05).
Conclusion: Improvement of functional MR contributes to LV reverse remodelling after CRT, whereas reduction of early-systolic MR is more powerful than late-systolic MR.
Comment in
-
Changes in functional mitral regurgitation after cardiac resynchronization therapy.Eur Heart J. 2010 Oct;31(19):2323-5. doi: 10.1093/eurheartj/ehq212. Epub 2010 Jul 8. Eur Heart J. 2010. PMID: 20616097 No abstract available.
Similar articles
-
Early and late effects of cardiac resynchronization therapy on exercise-induced mitral regurgitation: relationship with left ventricular dyssynchrony, remodelling and cardiopulmonary performance.Eur Heart J. 2007 Sep;28(17):2134-41. doi: 10.1093/eurheartj/ehm126. Epub 2007 May 15. Eur Heart J. 2007. PMID: 17504802
-
Repercussion of functional mitral regurgitation on reverse remodelling in cardiac resynchronization therapy.Europace. 2007 Sep;9(9):757-61. doi: 10.1093/europace/eum122. Epub 2007 Jun 15. Europace. 2007. PMID: 17573358
-
Differential change in left ventricular mass and regional wall thickness after cardiac resynchronization therapy for heart failure.Eur Heart J. 2006 Jun;27(12):1423-30. doi: 10.1093/eurheartj/ehi885. Epub 2006 Apr 13. Eur Heart J. 2006. PMID: 16682380
-
Role of cardiac dyssynchrony and resynchronization therapy in functional mitral regurgitation.Eur Heart J Cardiovasc Imaging. 2016 May;17(5):471-80. doi: 10.1093/ehjci/jev352. Epub 2016 Feb 2. Eur Heart J Cardiovasc Imaging. 2016. PMID: 26837899 Review.
-
Mitral valve regurgitation and left ventricular systolic dysfunction: corrective surgery or cardiac resynchronization therapy?Herzschrittmacherther Elektrophysiol. 2008 Dec;19 Suppl 1:52-9. doi: 10.1007/s00399-008-0602-4. Herzschrittmacherther Elektrophysiol. 2008. PMID: 19169735 Review.
Cited by
-
Transcatheter reshaping of the mitral annulus in patients with functional mitral regurgitation: one-year outcomes of the MAVERIC trial.EuroIntervention. 2021 Jan 20;16(13):1106-1113. doi: 10.4244/EIJ-D-20-00484. EuroIntervention. 2021. PMID: 32718911 Free PMC article. Clinical Trial.
-
Evolution and prognosis of tricuspid and mitral regurgitation following cardiac implantable electronic devices: a systematic review and meta-analysis.Europace. 2024 Jul 2;26(7):euae143. doi: 10.1093/europace/euae143. Europace. 2024. PMID: 38812433 Free PMC article.
-
Current role of echocardiography in cardiac resynchronization therapy.Heart Fail Rev. 2017 Nov;22(6):699-722. doi: 10.1007/s10741-017-9636-1. Heart Fail Rev. 2017. PMID: 28714039 Review.
-
Effect of cardiac resynchronization therapy on mitral valve geometry: a novel aspect as "reversed mitral remodeling".Int J Cardiovasc Imaging. 2018 Jul;34(7):1029-1040. doi: 10.1007/s10554-018-1308-2. Epub 2018 Jan 31. Int J Cardiovasc Imaging. 2018. PMID: 29387972
-
Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial.Eur J Heart Fail. 2012 Aug;14(8):931-8. doi: 10.1093/eurjhf/hfs076. Epub 2012 May 21. Eur J Heart Fail. 2012. PMID: 22613584 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials